
Lyrab 20mg Injection
Marketer
Hetero Drugs Ltd
Salt Composition
Rabeprazole (20mg)
Overview Lyrab 20mg Injection
AcidGard 20mg Injection is a medication that diminishes gastric acid secretion. It treats stomach and intestinal acid-related disorders, including acid reflux, indigestion, peptic ulcers, and other conditions stemming from excessive acid production. AcidGard 20mg Injection offers rapid symptom relief and is used prophylactically against stress ulcers in critically ill patients and pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this intravenous injection, administered by a healthcare provider, is reserved for cases where oral medication is deemed unsuitable. Dosage and treatment duration are determined by your physician based on your condition and response. Consistent use as prescribed is vital, even with rapid symptom improvement. Dietary modifications—smaller, more frequent meals, avoiding caffeine, spicy foods, and fatty foods—can enhance treatment efficacy. Common, generally mild, side effects encompass nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome symptoms warrant medical attention. Prolonged use, particularly exceeding one year, may elevate the risk of bone fractures, especially at higher doses. Consult your physician about mitigating osteoporosis risk, potentially through calcium and vitamin D supplementation. Hypomagnesemia (low magnesium) has been reported in patients using this medication for three months or more, potentially causing fatigue, confusion, dizziness, muscle spasms, and arrhythmia. Your doctor may monitor your magnesium levels. AcidGard 20mg Injection is contraindicated for individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or osteoporosis. Pregnant or lactating women should seek medical advice before use. Alcohol consumption, exacerbating acid production, should be avoided. Refrain from operating machinery if dizziness or drowsiness occurs.
Uses of Lyrab 20mg Injection
Management of heartburn and peptic ulcers
Major Benefits of Lyrab 20mg Injection:
Administering this medication requires a healthcare professional; self-medication is strictly prohibited.
Common Side effects of Lyrab 20mg Injection:
- Nausea
- Vomiting
- Headache
- Dizziness
- Flatulence
- Diarrhea
- Stomach pain
- Thrombophlebitis
How to use Lyrab 20mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Lyrab 20mg Injection works:
Stomach acid is neutralized by the proton pump inhibitor Lyrab 20mg Injection, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Lyrab 20mg Injection and alcohol. Seek your physician's advice.
PregnancyCONSULT YOUR DOCTOR
The use of Lyrab 20mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of Lyrab 20mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Lyrab 20mg Injection's impact on driving ability is undetermined. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Lyrab 20mg Injection poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Patients with severe hepatic impairment should use Lyrab 20mg Injection cautiously, as dose modification may be necessary. A physician's consultation is advised.
What if you forget to take Lyrab 20mg Injection :
Omit a Lyrab 20mg Injection dose? Seek your physician's advice.
Facts to Know About Lyrab 20mg Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavior Class | Gastric acid suppressants |
